TRPA1 and Alzheimer disease: The toxic effect of amyloid-β on astrocytes, triggered by TRPA1 channel activation, is crucial to the progression of AD, and TRPA1 blockade prevents irreversible neuronal dysfunction (Paumier et al., 2022).